ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics


ANI Pharmaceuticals, Inc. (ANIP)

Today's Latest Price: $32.34 USD

0.21 (0.65%)

Updated Jan 19 4:00pm

Add ANIP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 483 in Biotech

See all "A" rated Strong Buy stocks

ANIP Stock Summary

  • Of note is the ratio of Ani Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; 25.46% of US stocks have a lower such ratio.
  • Over the past twelve months, ANIP has reported earnings growth of -167.35%, putting it ahead of only 11.64% of US stocks in our set.
  • In terms of volatility of its share price, ANIP is more volatile than 27.76% of stocks we're observing.
  • Stocks that are quantitatively similar to ANIP, based on their financial statements, market capitalization, and price volatility, are GTYH, RENN, NEPT, JMIA, and PGEN.
  • ANIP's SEC filings can be seen here. And to visit Ani Pharmaceuticals Inc's official web site, go to www.anipharmaceuticals.com.

ANIP Stock Price Chart Interactive Chart >

Price chart for ANIP

ANIP Price/Volume Stats

Current price $32.34 52-week high $68.19
Prev. close $32.13 52-week low $23.55
Day low $31.83 Volume 45,240
Day high $32.90 Avg. volume 61,822
50-day MA $29.36 Dividend yield N/A
200-day MA $31.34 Market Cap 399.66M

ANI Pharmaceuticals, Inc. (ANIP) Company Bio


ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company was founded in 2004 and is based in Baudette, Minnesota.


ANIP Latest News Stream


Event/Time News Detail
Loading, please wait...

ANIP Latest Social Stream


Loading social stream, please wait...

View Full ANIP Social Stream

Latest ANIP News From Around the Web

Below are the latest news stories about Ani Pharmaceuticals Inc that investors may wish to consider to help them evaluate ANIP as an investment opportunity.

ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 54% On Their Shares

It's nice to see the ANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ) share price up 11% in a week. Meanwhile over the last...

Yahoo | January 6, 2021

Impact of COVID-19 on Vaginal Fungi Infections Treatment Market SWOT Analysis by 2027 | Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals

The latest 100+ page survey report on Vaginal Fungi Infections Treatment Market is released by CMI covering various players of the industry selected from global geographies like North America (Covered in Chapter 6 and 13), United States, Canada, Mexico, Europe

OpenPR | January 5, 2021

Alagille Syndrome Market 2020-2026 Moving Towards Brighter Future | Major Giants – Endo Pharmaceuticals Inc, ANI Pharmaceuticals, Inc, Mylan N.V., Glenmark Pharmaceuticals Ltd, Amneal Pharmaceuticals LLC

In Alagille Syndrome Market report, a systematic investment analysis has been performed which forecasts impending opportunities for the market players. The statistical and numerical data that has been included in this market report is represented with the tables, graphs and

OpenPR | December 10, 2020

Should You Take Comfort From Insider Transactions At ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)?

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...

Yahoo | November 7, 2020

ANI Pharmaceuticals Inc (ANIP) Q3 2020 Earnings Call Transcript

At this time, I would like to welcome everyone to the ANI Pharmaceuticals Third Quarter 2020 Earnings Results Conference Call. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for ANI Pharmaceuticals. This is Lisa Wilson of In-Site Communications, Investor Relations for ANI.

Yahoo | November 5, 2020

Read More 'ANIP' Stories Here

ANIP Price Returns

1-mo 3.75%
3-mo 18.50%
6-mo 14.93%
1-year N/A
3-year -53.76%
5-year -7.15%
YTD 11.36%
2020 -52.91%
2019 36.98%
2018 -30.15%
2017 6.32%
2016 34.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9409 seconds.